Literature DB >> 19005993

Posterior microphthalmos versus nanophthalmos.

Arif O Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19005993     DOI： 10.1080/13816810802258862

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  11 in total

1.  Patients within the Broad Holoprosencephaly Spectrum have Distinct and Subtle Ophthalmologic Anomalies: Response to Khan.

Authors:  Daniel E Pineda-Alvarez; Benjamin D Solomon; Erich Roessler; Joan Z Balog; Donald W Hadley; Wadih M Zein; Brian P Brooks; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2012-02-07       Impact factor: 2.802

2.  Clinical features of posterior microphthalmic and nanophthalmic eyes.

Authors:  Jing-Jing Liu; Yi-Ye Chen; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  The genetic and clinical landscape of nanophthalmos and posterior microphthalmos in an Australian cohort.

Authors:  Owen M Siggs; Mona S Awadalla; Emmanuelle Souzeau; Sandra E Staffieri; Lisa S Kearns; Kate Laurie; Abraham Kuot; Ayub Qassim; Thomas L Edwards; Michael A Coote; Erica Mancel; Mark J Walland; Joanne Dondey; Anna Galanopoulous; Robert J Casson; Richard A Mills; Daniel G MacArthur; Jonathan B Ruddle; Kathryn P Burdon; Jamie E Craig
Journal:  Clin Genet       Date:  2020-03-05       Impact factor: 4.438

4.  Novel compound heterozygous mutations in the MFRP gene in a Japanese patient with posterior microphthalmos.

Authors:  Itsuka Matsushita; Hiroyuki Kondo; Akihiko Tawara
Journal:  Jpn J Ophthalmol       Date:  2012-05-09       Impact factor: 2.447

5.  Mutations in a novel serine protease PRSS56 in families with nanophthalmos.

Authors:  Andrew Orr; Marie-Pierre Dubé; Juan C Zenteno; Haiyan Jiang; Geraldine Asselin; Susan C Evans; Aurore Caqueret; Hesham Lakosha; Louis Letourneau; Julien Marcadier; Makoto Matsuoka; Christine Macgillivray; Mathew Nightingale; Simon Papillon-Cavanagh; Scott Perry; Sylvie Provost; Mark Ludman; Duane L Guernsey; Mark E Samuels
Journal:  Mol Vis       Date:  2011-07-12       Impact factor: 2.367

6.  Glaucoma in a patient with nanophthalmos.

Authors:  Kouros Nouri-Mahdavi; Naveed Nilforushan; Mohammad-Reza Razeghinejad; Heydar Amini; Shamira A Perera
Journal:  J Ophthalmic Vis Res       Date:  2011-07

7.  Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF.

Authors:  Owen M Siggs; Emmanuelle Souzeau; James Breen; Ayub Qassim; Tiger Zhou; Andrew Dubowsky; Jonathan B Ruddle; Jamie E Craig
Journal:  Mol Vis       Date:  2019-09-21       Impact factor: 2.367

8.  Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex.

Authors:  Juan Carlos Zenteno; Beatriz Buentello-Volante; Miguel A Quiroz-González; Miguel A Quiroz-Reyes
Journal:  Mol Vis       Date:  2009-09-05       Impact factor: 2.367

9.  Chronic central serous choroidopathy with severe visual loss in hyperopic microphthalmic identical twins.

Authors:  Annelies Fabry; Johan Blanckaert; Anita Leys
Journal:  GMS Ophthalmol Cases       Date:  2011-11-07

Review 10.  Nanophthalmos: A Review of the Clinical Spectrum and Genetics.

Authors:  Pedro C Carricondo; Thais Andrade; Lev Prasov; Bernadete M Ayres; Sayoko E Moroi
Journal:  J Ophthalmol       Date:  2018-05-09       Impact factor: 1.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.